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Ancestral sylvatic dengue virus type 1, which was iso-
lated from a monkey in 1972, was isolated from a patient 
with dengue fever in Malaysia. The virus is neutralized by 
serum of patients with endemic DENV-1 infection. Rare iso-
lation of this virus suggests a limited spillover infection from 
an otherwise restricted sylvatic cycle.
D
engue virus (DENV) is a mosquito-borne pathogen 
maintained  in  sylvatic  (nonhuman  primate/sylvatic 
mosquitoes)  and  endemic  (human/urban/peridomestic 
mosquitoes) cycles. The endemic form of DENV poses a 
serious health threat to >100 million persons living in den-
gue-endemic regions (1). The endemic form of DENV may 
have originated from adaptation of sylvatic DENV to either 
peridomestic/urban mosquitoes or nonhuman primate hosts 
100–1,500 years ago (2).
All 4 DENV genotypes are thought to have indepen-
dently evolved from a sylvatic ancestral lineage, perhaps in 
Malaysia (2). However, only sylvatic DENV-1, DENV-2, 
and DENV-4 have been isolated, and monkey seroconver-
sion against DENV-1, DENV-2, and DENV-3 has been 
demonstrated (3). Incidences of spillover infection involv-
ing sylvatic DENV-2 have been reported, but mainly in 
West Africa.
Sylvatic dengue may still be endemic to West Africa, 
especially in areas with dense human habitation near for-
est areas (4,5). Sporadic reports of sylvatic dengue may be 
the result of low incidence of severe forms of this disease 
in these regions. In contrast, infection with sylvatic den-
gue is rare in other parts of the world, especially in South-
east Asia where dengue is hyperendemic. Sylvatic DENVs 
(DENV-1, DENV-2, and DENV-4) were last isolated from 
monkeys in Malaysia in the 1970s (3).
During 2004–2007, a dramatic increase occurred in the 
number of suspected dengue cases in Malaysia; 155,424 
cases and 358 deaths were reported (6). DENV-1 was the 
predominant virus isolated and accounted for 68% of all 
DENVs isolated. This outbreak represented a third cycle 
that involved DENV-1 in Malaysia since the 1960s (7). We 
report isolation of DENV-1 that shared >97% genome se-
quence similarity to an ancestral DENV-1 isolated from a 
sentinel monkey in Malaysia in 1972 (3).
The Study
At least 442 DENV-1 isolates from the 2004–2007 
dengue outbreak were obtained from the Diagnostic Vi-
rology  Repository  at  the  University  of  Malaya  Medical 
Centre. Viral RNA was extracted from infected cell culture 
supernatants, and a 1-step reverse transcription–PCR am-
plification of the DENV-1 envelope gene was performed 
by using amplification primers (8). Amplified fragments 
were  purified  and  sequenced  by  Macrogen  Inc.  (Seoul, 
South Korea).
DENV-1 genome sequences from study isolates and 
those obtained from GenBank (Table 1) were used to con-
struct phylogenetic trees. Maximum clade credibility was 
inferred by using the Bayesian Markov chain Monte Carlo 
method implemented in BEAST version 1.5.2 (9). For sim-
plicity, only 10 new DENV-1 sequences from the study and 
47 from GenBank were analyzed.
Phylogenetic  trees  showed  6  distinct  DENV-1  sub-
genotypes:  3  ancestral  subgenotypes  (Hawaii/Japan, 
1940s; Thailand, 1960s; and Malaysia, 1972) and 3 major 
endemic subgenotypes (SI, SII, and SIII), which is con-
sistent with reported findings (8). An isolate identified as 
D1.Malaysia.36046/05  grouped  with  isolate  P72_1244, 
a  sylvatic  DENV-1  reportedly  isolated  from  a  sentinel 
monkey  in  Malaysia  in  1972.  Virus  envelope  gene  se-
quence shared >97% nt sequence similarities and >99% 
aa sequence similarities. There was only 1 aa difference 
at position 55, from valine in P72_1244 to isoleucine in 
D1.Malaysia.36046/05.
Focus-reduction  neutralization  tests  (FRNTs)  were 
performed  by  using  the  D1.Malaysia.36046/05  isolate. 
Serum samples from patients with primary dengue caused 
by DENV-1 SI and SII (Figure) were pooled and used in 
FRNTs as described (10). Neutralizing antibody titer was 
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Table 1. Sylvatic and endemic dengue virus isolates used in the 
study, Malaysia 
Isolate*
Year 
isolated
GenBank
accession no. 
D1.Malaysia.36046/05  2005  FN825674 
D1.Malaysia.32581/04  2004  FR666923 
D1.Malaysia.32858/04  2004  FR666921 
D1. Malaysia.33087/04  2004  FR666922 
D1. Malaysia.33370/04  2004  FR666923 
D1.Malaysia.36000/05  2005  FR666924 
D1.Malaysia.36139/05  2005  FR666925 
D1.Malaysia.32694/04  2004  FR666926 
D1.Malaysia.35765/05  2005  FR666927 
D1.Malaysia.35845/05  2005  FR666928 
*Isolate D1.Malaysia.36046/05 is a sylvatic type. All other isolates are 
endemic types.  defined as the reciprocal of the highest serum dilution that 
reduced viral foci by 50% (FRNT50). FRNT results after 
adjustment of the titer to that of respective isolates showed 
that the D1.Malaysia.36046/05 virus is neutralized by se-
rum from patients with DENV-1 SI infections (FRNT50 = 
320) and samples from patients with DENV-1 SII infec-
tions (FRNT50 = 80) (Table 2).
Laboratory  and  clinical  records  showed  that 
D1.Malaysia.36046/05 virus was isolated from a patient 
who had headache, body ache, chills, rigors, and abdomi-
nal pain for 3 days and sought treatment at the University 
of Malaya Medical Centre. The patient was treated as an 
outpatient  and  suspected  of  having  dengue  fever.  Sero-
logic results for dengue immunoglobulin M were negative. 
D1.Malaysia.36046/05 was isolated and identified initially 
as DENV-1 by using immunofluorescent antibody staining. 
The patient did not return for subsequent follow-up, and 
efforts to locate the patient were unsuccessful. The most 
recent address of the patient was within a high population–
density area of Kuala Lumpur. Additional sequencing of 
other DENV-1 isolates from the 2004–2007 outbreak did 
not identify any additional D1.Malaysia.36046/05–like vi-
rus.
Conclusions
Isolation of the ancestral DENV-1 after >30 years sug-
gests that a mosquito–host transmission cycle has main-
tained this virus. This rare isolation of the virus suggests a 
restricted transmission cycle. The natural host of the virus 
cannot be determined conclusively because the only known 
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Figure. Maximum clade credibility tree of complete envelope genes of dengue virus type 1 (DENV-1) isolates. Horizontal branches are 
drawn to a scale of estimated year of divergence. Coalescent times with 95% highest posterior density values (ranges in parentheses) and 
posterior probability values (all 1.0) of key nodes are shown. Patient convalescent-phase serum samples used for neutralization assays 
from which virus was isolated are indicated at the end of branches according to their virus groups. Box indicates sylvatic DENV-1 isolated 
in the study. New sequences were used to create the phylogenetic tree are as in Table 1. SII, subgenotype II, SI, subgenotype I.Ancestral Dengue Virus, Malaysia
fact is that the virus was isolated from a patient with den-
gue fever. The original ancestral DENV-1 isolate P72_1244 
was designated as sylvatic because it was isolated from a 
sentinel monkey in a rural forest (3). Its sylvatic origin 
has recently become uncertain because the virus genome 
is phylogenetically closer to other endemic DENV-1 lin-
eages (11). However, because no virus with high sequence 
similarities to that of DENV-1 isolate P72_1244 has been 
isolated over the past 33 years, the virus may have been 
maintained in a sylvatic cycle through a nonhuman pri-
mate/mosquito enzootic cycle.
The  estimated  sequence  evolution  rate  for 
D1.Malaysia.36046/05  is  5.20  ×  10–4  substitutions/site/
year.  This  rate  is  relatively  slower  than  those  for  other 
endemic DENV-1 isolates used in this study (5.67 × 10–4 
to 8.05 × 10–4 substitutions/site/year). The much smaller 
monkey:human  population  ratio  (700,000:28,000,000) 
(12) (http://en.wikipedia.org/wiki/Malaysia) and the more 
restricted mobility of monkeys could have limited the virus 
genome sequence divergence, leading to conservation of 
the sylvatic virus genome sequence.
The absence of the virus from the endemic urban cycle 
over the past 33 years could have been caused by its inabil-
ity to overcome population herd immunity after exposure 
to endemic DENV-1. Efficient neutralization of virus by 
serum from patients infected with DENV-1 SI and SII sup-
ports this possibility (13). Conversely, the virus may not 
be highly transmissible by peridomestic mosquitoes (14) 
and may be confined to the enzootic forest cycle. There-
fore, isolation of the ancestral virus from a person living 
in Kuala Lumpur is most likely the result of a stochastic 
spillover event after contact with infected forest-dwelling 
mosquitoes.
We report isolation of an ancestral sylvatic DENV-1 
from an infected person. Available evidence does not sup-
port  endemic  presence  of  the  virus  in  an  urban  dengue 
cycle. However, a sylvatic cycle needs to be considered in 
any future dengue vaccination initiatives.
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Table 2. Serum neutralization of ancestral sylvatic dengue virus 
isolate D1/Malaysia/36046/05, Malaysia* 
Serum group*  Neutralizing antibody titer† 
Mock 0
Virus 0
Medium 0
SI 320
SII 80
*Mock, controls treated with serum from healthy (no dengue infection) 
donors; virus, virus plus diluent; medium, serum and diluent without virus; 
SI, subgenotype I; SII, subgenotype II. 
†Reciprocal of the highest serum dilution that reduced viral foci by 50% 
(50% focus-reduction neutralization test). Serum from patients infected 
with sylvatic virus was not available. Virus was treated with serum from 
patients infected with primary dengue virus type 1 SI or SII.  